GNI Group
After graduating from Waseda University with a degree in Commerce, Hideaki Sashiwa has worked with some major securities companies including Daiwa Securities Co.Ltd, Kleinwort Benson, and Goldman Sachs where he cultivated his specialized knowledge about finance and investment. He is currently the President of Nippon Concierge Co., Ltd. and Representative Director and Vice-President of GI Capital Securities Ltd.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
GNI Group
GNI Group Ltd. is a Japan-based company engaged in new drug production activities utilizing biotechnologies. The Company is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. It is engaged in research and development of therapeutic agents, including F647 for radiation pneumonia (RP) and idiopathic pulmonary fibrosis (IPF), F351 for liver fibrosis (cirrhosis) and F573 for acute hepatic insufficiency and acute chronic liver failure (ACLF).